Format
Items per page
Sort by

Send to:

Choose Destination

Results: 20

1.

Striatal metabolism and psychomotor speed as predictors of motor onset in Huntington's disease.

Herben-Dekker M, van Oostrom JC, Roos RA, Jurgens CK, Witjes-Ané MN, Kremer HP, Leenders KL, Spikman JM.

J Neurol. 2014 Jul;261(7):1387-97. doi: 10.1007/s00415-014-7350-7. Epub 2014 Apr 30.

PMID:
24781835
2.

Suicidal ideation in a European Huntington's disease population.

Hubers AA, van Duijn E, Roos RA, Craufurd D, Rickards H, Bernhard Landwehrmeyer G, van der Mast RC, Giltay EJ; REGISTRY investigators of the European Huntington's Disease Network.

J Affect Disord. 2013 Oct;151(1):248-58. doi: 10.1016/j.jad.2013.06.001. Epub 2013 Jul 20.

3.

β-Defensin genomic copy number does not influence the age of onset in Huntington's Disease.

Vittori A, Orth M, Roos RA, Outeiro TF, Giorgini F, Hollox EJ; Registry investigators of the European Huntington's Disease Network.

J Huntingtons Dis. 2013;2(1):107-24. doi: 10.3233/JHD-130002.

PMID:
25057107
4.

CAG repeat expansion in Huntington disease determines age at onset in a fully dominant fashion.

Lee JM, Ramos EM, Lee JH, Gillis T, Mysore JS, Hayden MR, Warby SC, Morrison P, Nance M, Ross CA, Margolis RL, Squitieri F, Orobello S, Di Donato S, Gomez-Tortosa E, Ayuso C, Suchowersky O, Trent RJ, McCusker E, Novelletto A, Frontali M, Jones R, Ashizawa T, Frank S, Saint-Hilaire MH, Hersch SM, Rosas HD, Lucente D, Harrison MB, Zanko A, Abramson RK, Marder K, Sequeiros J, Paulsen JS; PREDICT-HD study of the Huntington Study Group (HSG), Landwehrmeyer GB; REGISTRY study of the European Huntington's Disease Network, Myers RH; HD-MAPS Study Group, MacDonald ME, Gusella JF; COHORT study of the HSG.

Neurology. 2012 Mar 6;78(10):690-5. doi: 10.1212/WNL.0b013e318249f683. Epub 2012 Feb 8.

5.

Seven-year clinical follow-up of premanifest carriers of Huntington's disease.

Hart E, Middelkoop H, Jurgens CK, Witjes-Ané MN, Roos RA.

PLoS Curr. 2011 Nov 30;3:RRN1288. doi: 10.1371/currents.RRN1288.

6.

NMDA receptor gene variations as modifiers in Huntington disease: a replication study.

Saft C, Epplen JT, Wieczorek S, Landwehrmeyer GB, Roos RA, de Yebenes JG, Dose M, Tabrizi SJ, Craufurd D; REGISTRY Investigators of the European Huntington's Disease Network, Arning L.

PLoS Curr. 2011 Oct 4;3:RRN1247. doi: 10.1371/currents.RRN1247.

7.

Discrepancies in reporting the CAG repeat lengths for Huntington's disease.

Quarrell OW, Handley O, O'Donovan K, Dumoulin C, Ramos-Arroyo M, Biunno I, Bauer P, Kline M, Landwehrmeyer GB; European Huntington’s Disease Network.

Eur J Hum Genet. 2012 Jan;20(1):20-6. doi: 10.1038/ejhg.2011.136. Epub 2011 Aug 3.

8.

Basal ganglia volume is strongly related to P3 event-related potential in premanifest Huntington's disease.

Jurgens CK, van der Hiele K, Reijntjes RH, van de Wiel L, Witjes-Ané MN, van der Grond J, Roos RA, Middelkoop HA, van Dijk JG.

Eur J Neurol. 2011 Aug;18(8):1105-8. doi: 10.1111/j.1468-1331.2010.03309.x. Epub 2011 Jan 25.

PMID:
21749577
9.

What is the impact of education on Huntington's disease?

López-Sendón JL, Royuela A, Trigo P, Orth M, Lange H, Reilmann R, Keylock J, Rickards H, Piacentini S, Squitieri F, Landwehrmeyer B, Witjes-Ane MN, Jurgens CK, Roos RA, Abraira V, de Yébenes JG; European HD Network.

Mov Disord. 2011 Jul;26(8):1489-95. doi: 10.1002/mds.23385. Epub 2011 Mar 22.

PMID:
21432905
10.

Observing Huntington's disease: the European Huntington's Disease Network's REGISTRY.

Orth M; European Huntington's Disease Network, Handley OJ, Schwenke C, Dunnett S, Wild EJ, Tabrizi SJ, Landwehrmeyer GB.

J Neurol Neurosurg Psychiatry. 2011 Dec;82(12):1409-12. doi: 10.1136/jnnp.2010.209668. Epub 2010 Nov 19. No abstract available.

PMID:
21097549
11.

Observing Huntington's Disease: the European Huntington's Disease Network's REGISTRY.

Orth M, Handley OJ, Schwenke C, Dunnett SB, Craufurd D, Ho AK, Wild E, Tabrizi SJ, Landwehrmeyer GB; Investigators of the European Huntington's Disease Network.

Version 2. PLoS Curr. 2010 Sep 28 [revised 2011 Apr 13];2:RRN1184.

12.

MRI T2 Hypointensities in basal ganglia of premanifest Huntington's disease.

Jurgens CK, Jasinschi R, Ekin A, Witjes-Ané MN, Middelkoop H, van der Grond J, Roos RA.

PLoS Curr. 2010 Sep 8;2. pii: RRN1173. doi: 10.1371/currents.RRN1173.

13.

Magnetization transfer imaging in 'premanifest' Huntington's disease.

Jurgens CK, Bos R, Luyendijk J, Witjes-Ané MN, van der Grond J, Middelkoop HA, Roos RA.

J Neurol. 2010 Mar;257(3):426-32. doi: 10.1007/s00415-009-5339-4. Epub 2009 Oct 13.

14.

Normal and mutant HTT interact to affect clinical severity and progression in Huntington disease.

Aziz NA, Jurgens CK, Landwehrmeyer GB; EHDN Registry Study Group, van Roon-Mom WM, van Ommen GJ, Stijnen T, Roos RA.

Neurology. 2009 Oct 20;73(16):1280-5. doi: 10.1212/WNL.0b013e3181bd1121. Epub 2009 Sep 23. Erratum in: Neurology. 2011 Jan 11;76(2):202. Ciarmielo, Andrea [corrected to Ciarmiello, Andrea]. Neurology. 2009 Nov 10;73(19):1608.

PMID:
19776381
15.

Biological and clinical manifestations of Huntington's disease in the longitudinal TRACK-HD study: cross-sectional analysis of baseline data.

Tabrizi SJ, Langbehn DR, Leavitt BR, Roos RA, Durr A, Craufurd D, Kennard C, Hicks SL, Fox NC, Scahill RI, Borowsky B, Tobin AJ, Rosas HD, Johnson H, Reilmann R, Landwehrmeyer B, Stout JC; TRACK-HD investigators.

Lancet Neurol. 2009 Sep;8(9):791-801. doi: 10.1016/S1474-4422(09)70170-X. Epub 2009 Jul 29.

16.

Basal ganglia volume and clinical correlates in 'preclinical' Huntington's disease.

Jurgens CK, van de Wiel L, van Es AC, Grimbergen YM, Witjes-Ané MN, van der Grond J, Middelkoop HA, Roos RA.

J Neurol. 2008 Nov;255(11):1785-91. doi: 10.1007/s00415-008-0050-4. Epub 2008 Dec 8.

PMID:
19156490
17.

Longitudinal evaluation of "presymptomatic" carriers of Huntington's disease.

Witjes-Ané MN, Mertens B, van Vugt JP, Bachoud-Lévi AC, van Ommen GJ, Roos RA.

J Neuropsychiatry Clin Neurosci. 2007 Summer;19(3):310-7.

PMID:
17827417
18.

Memory activation reveals abnormal EEG in preclinical Huntington's disease.

van der Hiele K, Jurgens CK, Vein AA, Reijntjes RH, Witjes-Ané MN, Roos RA, van Dijk G, Middelkoop HA.

Mov Disord. 2007 Apr 15;22(5):690-5.

PMID:
17266047
19.

Cognitive and motor functioning in gene carriers for Huntington's disease: a baseline study.

Witjes-Ané MN, Vegter-van der Vlis M, van Vugt JP, Lanser JB, Hermans J, Zwinderman AH, van Ommen GJ, Roos RA.

J Neuropsychiatry Clin Neurosci. 2003 Winter;15(1):7-16.

PMID:
12556566
20.

Behavioural complaints in participants who underwent predictive testing for Huntington's disease.

Witjes-Ané MN, Zwinderman AH, Tibben A, van Ommen GJ, Roos RA.

J Med Genet. 2002 Nov;39(11):857-62. No abstract available.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk